These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38660364)

  • 21. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
    Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
    Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection.
    Vaira LA; Lechien JR; Salzano G; Maglitto F; Boscolo-Rizzo P; Hopkins C; De Riu G
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1249-1252. PubMed ID: 36821798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of self-reported smell and taste disorders in suspected COVID‑19.
    Printza A; Constantinidis J
    Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2625-2630. PubMed ID: 32447496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtle olfactory dysfunction after SARS-CoV-2 virus infection in children.
    Concheiro-Guisan A; Fiel-Ozores A; Novoa-Carballal R; González-Duran ML; Portugués de la Red M; Martínez-Reglero C; Fernández-Pinilla I; González-Guijarro I
    Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110539. PubMed ID: 33307419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
    Lechner M; Chandrasekharan D; Jumani K; Liu J; Gane S; Lund VJ; Philpott C; Jayaraj S
    Rhinology; 2020 Aug; 58(4):394-399. PubMed ID: 32386285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
    PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of subjective and tested olfactory dysfunction as a screening tool for COVID-19 in children.
    Danielsen LMA; Fjældstad AW; Ovesen T
    Dan Med J; 2023 Apr; 70(5):. PubMed ID: 37125823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smell dysfunction: a biomarker for COVID-19.
    Moein ST; Hashemian SM; Mansourafshar B; Khorram-Tousi A; Tabarsi P; Doty RL
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):944-950. PubMed ID: 32301284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
    Soni A; Herbert C; Filippaios A; Broach J; Colubri A; Fahey N; Woods K; Nanavati J; Wright C; Orwig T; Gilliam K; Kheterpal V; Suvarna T; Nowak C; Schrader S; Lin H; O'Connor L; Pretz C; Ayturk D; Orvek E; Flahive J; Lazar P; Shi Q; Achenbach C; Murphy R; Robinson M; Gibson L; Stamegna P; Hafer N; Luzuriaga K; Barton B; Heetderks W; Manabe YC; McManus D
    Ann Intern Med; 2022 Dec; 175(12):1685-1692. PubMed ID: 36215709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Smell in COVID-19 Infection: Diagnostic Opportunities.
    David P; Shoenfeld Y
    Isr Med Assoc J; 2020 Jul; 22(7):401-403. PubMed ID: 33236562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results.
    Lan FY; Filler R; Mathew S; Buley J; Iliaki E; Bruno-Murtha LA; Osgood R; Christophi CA; Fernandez-Montero A; Kales SN
    PLoS One; 2020; 15(6):e0235460. PubMed ID: 32589687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of formal smell testing and symptom screening for identifying SARS-CoV-2 infection.
    Keck JW; Bush M; Razick R; Mohammadie S; Musalia J; Hamm J
    PLoS One; 2022; 17(4):e0266912. PubMed ID: 35413084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2).
    Hintschich CA; Vielsmeier V; Bohr C; Hagemann J; Klimek L
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5445-5447. PubMed ID: 35767061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
    Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
    JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.